lamivudine has been researched along with cepharanthine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Baba, M; Okamoto, M; Okamoto, T | 1 |
| Jiang, JH; Ma, F; Sun, CY; Wang, N; Wang, QD; Wang, YF; Yang, XA; Yin, DT; Zhang, Y; Zheng, LY; Zhou, YB | 1 |
3 other study(ies) available for lamivudine and cepharanthine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
Topics: Alkaloids; Anti-HIV Agents; Anti-Infective Agents; Benzylisoquinolines; Cell Line; Drug Synergism; Fluoroquinolones; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Nelfinavir; Nevirapine; NF-kappa B; Piperazines; Reverse Transcriptase Inhibitors; Tumor Necrosis Factor-alpha; Virus Replication; Zidovudine | 1999 |
In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates.
Topics: Adult; Antiviral Agents; Benzylisoquinolines; Cell Survival; China; DNA, Viral; Down-Regulation; Drug Resistance, Viral; Gene Expression Regulation, Viral; Hep G2 Cells; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatocytes; HSC70 Heat-Shock Proteins; Humans; Inhibitory Concentration 50; Lamivudine; Male; Recombinant Proteins; RNA, Messenger; Virus Replication | 2012 |